ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 55 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $362,000 | -19.6% | 1,005,300 | -1.3% | 0.00% | -100.0% |
Q1 2017 | $450,000 | -13.0% | 1,019,000 | -1.5% | 0.00% | 0.0% |
Q4 2016 | $517,000 | +12.4% | 1,034,500 | +13.9% | 0.00% | 0.0% |
Q3 2016 | $460,000 | -47.5% | 908,100 | +3.7% | 0.00% | -50.0% |
Q2 2016 | $876,000 | +59.0% | 876,100 | +8.6% | 0.00% | +100.0% |
Q1 2016 | $551,000 | -39.8% | 806,700 | +6.6% | 0.00% | -50.0% |
Q4 2015 | $916,000 | -42.8% | 757,000 | +5.5% | 0.00% | -50.0% |
Q3 2015 | $1,600,000 | -17.9% | 717,400 | -14.3% | 0.00% | 0.0% |
Q2 2015 | $1,950,000 | +43.9% | 837,023 | +32.8% | 0.00% | +33.3% |
Q1 2015 | $1,355,000 | +53.5% | 630,391 | +63.5% | 0.00% | +50.0% |
Q4 2014 | $883,000 | +39.9% | 385,483 | +63.1% | 0.00% | 0.0% |
Q3 2014 | $631,000 | -39.6% | 236,415 | -15.5% | 0.00% | 0.0% |
Q2 2014 | $1,044,000 | -0.9% | 279,922 | +212.7% | 0.00% | -33.3% |
Q1 2014 | $1,053,000 | +48.9% | 89,522 | +5.6% | 0.00% | +50.0% |
Q4 2013 | $707,000 | +46.1% | 84,800 | +62.5% | 0.00% | +100.0% |
Q3 2013 | $484,000 | +49.4% | 52,200 | +57.7% | 0.00% | 0.0% |
Q2 2013 | $324,000 | – | 33,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Chapters Capital Management LLC | 17,200 | $9,000 | 0.02% |
TWO SIGMA SECURITIES, LLC | 18,332 | $9,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 949,438 | $475,000 | 0.00% |
Virtu KCG Holdings LLC | 58,727 | $29,000 | 0.00% |
Renaissance Technologies | 1,034,500 | $517,000 | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $23,000 | 0.00% |
DEUTSCHE BANK AG\ | 5 | $0 | 0.00% |
CITIGROUP INC | 10,376 | $5,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 17,280 | $9,000 | 0.00% |
MORGAN STANLEY | 8,500 | $4,000 | 0.00% |